CMS Open Payments · Program Year 2024
MeMed US, Inc.
MeMed US, Inc. reported $7,651.94 across General Payments, Research, and Ownership to 25 physicians and teaching hospitals across 25 transactions.
- $7.7K Below-median payer
- All-tracks total
- 25 Below-median volume
- Transactions
- 25 Below-median reach
- Recipients
- #1668
- of 1,925 companies
MeMed US, Inc. reported $7,651.94 across all CMS Open Payments tracks (General + Research + Ownership) to 25 physicians and teaching hospitals in Program Year 2024 - ranking #1668 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $7,651.94, averaging $306.08 per recipient.
MeMed US, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer memed-us-inc MeMed US, Inc.
$7.7K · #1668/1,925 · 0.0% industry · PY2024
- TOT $7.7K
- RANK #1668
- SHARE 0.0%
- TXN 25
- RCP 25
- CAT 4
- GEN $7.7K
- TOP1 21.9%
- PY 2024
Volume peers
Nearest volume peer: Poriferous LLC ($7.6K)
MeMed US, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for MeMed US, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For MeMed US, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
18 transactions worth $3.7K make "Food and Beverage" the top general-payment category in the 4-category breakdown below, 48.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads MeMed US, Inc.'s 4-category general-payment breakdown at $3.7K, 48.1% of the reported total.
MeMed US, Inc. reports 4 general-payment categories - the top three are Food and Beverage (48.1%), Consulting Fee (47.0%), and Entertainment (2.5%). The remaining 1 category make up 2.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How MeMed US, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $3.7K | 18 | 48.1% |
| Consulting Fee | $3.6K | 3 | 47.0% |
| Entertainment | $188.50 | 1 | 2.5% |
| Education | $184.68 | 3 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $4,950.24 (64.7%) of $7,651.94 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for MeMed US, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Eric Weinberg
$1,673.30 across 2 reported transactions
- 2
Brian Cruz
$1,273.30 across 2 reported transactions
- 3
David Mathison
$800.00 across 1 reported transactions
- 4
Randall Colvin
$716.62 across 1 reported transactions
- 5
David Rorison
$487.02 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
MeMed US, Inc. ranks #1668 of 1,925 by total payments (bottom 13% by spend) but is notably more concentrated than that alone would suggest -- #981 of 1,838 by HHI (bottom 47% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- MY01 Inc. : $29.5K total payments, HHI 1134
- Whitehall International Inc : $44.4K total payments, HHI 1133
- Prismatik Dentalcraft, Inc. : $485.7K total payments, HHI 1132
- Gamida Cell Inc. : $31.5K total payments, HHI 1127
- Voom Medical Devices, Inc. : $76.9K total payments, HHI 1125
- Cryo Specialty Medical, LLC : $117.5K total payments, HHI 1121
- MeMed US, Inc. (this company) : $7.7K total payments, HHI 1121
- MiRus, LLC : $236.9K total payments, HHI 1119
- Echosens North America, Inc. : $149.4K total payments, HHI 1118
- Curium US LLC : $45.9K total payments, HHI 1118
- Noah Medical Corporation : $1.2M total payments, HHI 1114
- Life Technologies Corporation : $868.1K total payments, HHI 1114
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as MeMed US, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about MeMed US, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with MeMed US, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Kedrion S.p.A.
Biedermann Motech, Inc.
Next Orthosurgical, Inc
Quest Medical Imaging, Inc
Novo Nordisk US Research & Development, Inc.
Put this to use
MeMed US, Inc. ranks #1668 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just MeMed US, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.